Web29 mrt. 2024 · As the leader in RNA-targeted therapeutics for more than three decades, Ionis has focused every moment on advancing drug discovery, development, and … Web15 jun. 2024 · IONS has a market cap of $4.93bn and a cash balance of $2.1bn. The company made $142mn in the previous quarter from SPINRAZA. They had a GAAP net loss of $65mn, and operating expenses were $199mn....

IONIS PHARMACEUTICALS, INC.: koers Aandeel beurs IONS

WebIonis Pharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "IONS". What is Ionis Pharmaceuticals's primary industry? ... Ionis Pharmaceuticals's … Web11 apr. 2024 · News zur IONIS PHARMACEUTICALS AKTIE und aktueller Realtime-Aktienkurs AstraZeneca-Ionis Partnered Rare Disease Drug ... US4622221004 Ticker … razer gold gcash

IONS: Ionis Pharmaceuticals Inc Stock Price Quote - Bloomberg

Web17 mrt. 2024 · Aandeel Ionis Pharmaceuticals OTC:IONS.Q, US4622221004 Vertraagde koers Settlement koers (usd) 35,180 17 mrt 2024 21:00 Verschil +0,180 (+0,51%) … Web26 jul. 2024 · To learn more about Ionis visit www.ionispharma.com and follow us on twitter @ionispharma. Ionis' Forward-looking Statement. This press release includes forward-looking statements regarding Ionis’ business and the therapeutic and commercial potential of Ionis' technologies, IONIS-MAPTRx/BIIB080 and other products in development. WebTicker IONS Exchange NASDAQ More Industry Biotechnology More Sector Healthcare More 501-1000 Employees Based in Carlsbad, California Ionis is the leading company in RNA-targeted drug discovery and development focused on developing drugs for patients who have the highest unmet medical needs, such as those patients with severe and rare … razer gold gift card 100